Results 91 to 100 of about 30,735 (203)

Stereotactic body radiotherapy for liver tumors: Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy

, 2014
PURPOSE: This report of the Working Group on Stereotactic Radiotherapy of the German Society of Radiation Oncology (DEGRO) aims to provide a practical guideline for safe and effective stereotactic body radiotherapy (SBRT) of liver tumors.
Herfarth, Klaus, Ernst, I, Greve, B, Brunner, T B, Sterzing, F, Brunner, Thomas, Greve, Burkhard, Guckenberger, Matthias, Baus, W W, Herfarth, K, Baus, Wolfgang, Guckenberger, M, Sterzing, Florian, Ernst, Iris   +13 more
core   +1 more source

Premature Termination of a Randomized Controlled Trial on Image-Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression

, 2020
LESSONS LEARNED: It is possible to plan and treat some patients with stereotactic body radiotherapy (SBRT) in a timely fashion in an acute setting.Advanced and, in some indications, already implemented technologies such as SBRT are difficult to test in a
Munck Af Rosenschold, Per, Berthelsen, Anne Kiil, Pappot, Helle, Suppli, Morten Hiul, Engelholm, Svend Aage, Dahl, Benny   +5 more
core   +1 more source

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview

, 2023
Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been recognized as an alternative therapy for patients for whom standard modalities such
Yukinori Matsuo
core   +1 more source

Transporter‐Associated Therapeutic Efficacy of an SMVT‐Targeted Boron Carrier in Boron Neutron Capture Therapy

Cancer Science, EarlyView.
The transporter‐associated BNCT strategy using BBCIP with or without BPA according to tumor transporter characteristics. BPA showed greater efficacy in LAT1‐dominant F98 glioma, whereas BBCIP was more effective in SMVT‐high CRL1666 tumors, suggesting the potential utility of transporter‐based boron carrier selection in BNCT.
Kenichiro Eza, Kohei Tsujino, Rina Shidoh‐Kazuki, Yoshiki Fujikawa, Hideki Kashiwagi, Gen Futamura, Ryo Hiramatsu, Toshihiro Takami, Masahiko Wanibuchi, Naonori Hu, Hiroki Tanaka, Minoru Suzuki, Kai Nishimura, Shota Tanaka, Hiroyuki Nakamura, Shinji Kawabata   +15 more
wiley   +1 more source

Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer

, 2011
Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome.
Derek Grose MRCP, FRCR, Robert Milroy, Grose, Derek, Milroy, Robert   +3 more
core   +1 more source

Optimal planning strategy among various arc arrangements for prostate stereotactic body radiotherapy with volumetric modulated arc therapy technique

Radiology and Oncology, 2017
The aim of this study was to determine the optimal strategy among various arc arrangements in prostate plans of stereotactic body radiotherapy with volumetric modulated arc therapy (SBRT-VMAT).
Kang Sang Won, Chung Jin Beom, Kim Jae Sung, Kim In Ah, Eom Keun Yong, Song Changhoon, Lee Jeong Woo, Kim Jin Young, Suh Tae Suk   +8 more
doaj   +1 more source

Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques ‐ Review

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Several benign, inflammatory and malignant lesions can present as iris or anterior chamber masses, including iris naevi, cysts, adenomas, leiomyomas, nodules, vascular tumours, melanomas, metastases, as well as iris and pigment epithelium adenocarcinomas. Fortunately, benign iris lesions are much more common than malignant tumours and many can
Charles N. J. McGhee, Joevy Z. Lim, Peter W. Hadden, Jie Zhang   +3 more
wiley   +1 more source

Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions

Med Research, EarlyView.
Zhiwu Dong, Sixiang Yan, Xiaodong Liu, Peng Gu   +3 more
wiley   +1 more source

Closing the gap – lung cancer evaluation and treatment among indigenous and non‐indigenous patients in the Top End, Northern Territory, Australia

Internal Medicine Journal, EarlyView.
ABSTRACT Background Lung cancer outcomes have been reported to be poorer in the indigenous population of the Northern Territory (NT). We examine whether longer diagnostic and treatment time frames contribute to the observed survival disparity. Aims Assess the time frames to diagnosis and treatment of lung cancer in the Top End, NT, Australia.
Angus Lloyd, Paul DeKlerk, Subash Heraganahally, Lin Mo   +3 more
wiley   +1 more source

Stereotactic body radiotherapy for solitary spine metastasis [PDF]

, 2013
A clear consensus has not been established regarding the best treatment for solitary bone metastasis. Here, we reviewed the medical records of patients with a controlled primary malignancy who had only solitary spine metastasis without metastasis to the ...
Lee, M, Chun, M, Lee, S
core